関連レポート

酵素の世界市場：2027年に至る酵素タイプ別、用途別予測

出版元：Transparency Market Research  出版元について

発行年：2024年2月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 220ページになります。

商品コード：TMR221

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

診断用酵素の世界市場規模は2022年で10億ドル、2031年に18億ドル、市場の平均年成長率は6.9%にて増加する見込みです。

当レポートでは、診断用酵素の市場予測-2031年、各種セグメント別市場分析(製品別、用途別、国地域別、等)、市場ダイナミクス、パイプライン分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■診断用酵素の世界市場予測2023-2031年
・市場規模(US$)

■製品別、市場-2031年
・プロテアーゼ
・カーボハイドラーゼ
・ポリメラーゼ/ヌクレアーゼ
・酸化酵素
・その他
※(市場規模US$)　

■用途別、市場-2031年
臨床化学
・POC 検査
・血糖モニタリング
・その他
分子診断
免疫測定
その他
※(市場規模US$)

■主要国地域別市場-2031年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・ASEAN、韓国
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス
パイプライン分析
主要製品/ブランド分析
主要な合併、買収

■診断用酵素の主要企業プロフィール動向
F. Hoffmann-La Roche Ltd.
Novozymes A/S
Codexis, Inc.
BBI Solutions
Biocatalysts Ltd.
Advanced Enzymes Technologies Ltd.
American Laboratories, Inc.
Thermo Fisher Scientific Inc.
天野エンザイム株式会社
Amicogen

（全220頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Diagnostic Specialty Enzymes Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, 2017–2031

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Proteases
6.3.2. Carbohydrases
6.3.3. Polymerases & Nucleases
6.3.4. Oxidases
6.3.5. Others
6.4. Market Attractiveness Analysis, by Product

7. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Clinical Chemistry
7.3.1.1. POC Testing
7.3.1.2. Blood Glucose Monitoring
7.3.1.3. Others
7.3.2. Molecular Diagnostics
7.3.3. Immunoassay
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application

8. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region

9. North America Diagnostic Specialty Enzymes Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Product, 2017–2031
9.3.1. Proteases
9.3.2. Carbohydrases
9.3.3. Polymerases & Nucleases
9.3.4. Oxidases
9.3.5. Others
9.4. Market Value Forecast, by Application, 2017–2031
9.4.1. Clinical Chemistry
9.4.1.1. POC Testing
9.4.1.2. Blood Glucose Monitoring
9.4.1.3. Others
9.4.2. Molecular Diagnostics
9.4.3. Immunoassay
9.4.4. Others
9.5. Market Value Forecast, by Country, 2017–2031
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Application
9.6.3. By Country

10. Europe Diagnostic Specialty Enzymes Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2017–2031
10.3.1. Proteases
10.3.2. Carbohydrases
10.3.3. Polymerases & Nucleases
10.3.4. Oxidases
10.3.5. Others
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Clinical Chemistry
10.4.1.1. POC Testing
10.4.1.2. Blood Glucose Monitoring
10.4.1.3. Others
10.4.2. Molecular Diagnostics
10.4.3. Immunoassay
10.4.4. Others
10.5. Market Value Forecast, by Country/Sub-region, 2017–2031
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By Country/Sub-region

11. Asia Pacific Diagnostic Specialty Enzymes Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2017–2031
11.3.1. Proteases
11.3.2. Carbohydrases
11.3.3. Polymerases & Nucleases
11.3.4. Oxidases
11.3.5. Others
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Clinical Chemistry
11.4.1.1. POC Testing
11.4.1.2. Blood Glucose Monitoring
11.4.1.3. Others
11.4.2. Molecular Diagnostics
11.4.3. Immunoassay
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By Country/Sub-region

12. Latin America Diagnostic Specialty Enzymes Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2017–2031
12.3.1. Proteases
12.3.2. Carbohydrases
12.3.3. Polymerases & Nucleases
12.3.4. Oxidases
12.3.5. Others
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Clinical Chemistry
12.4.1.1. POC Testing
12.4.1.2. Blood Glucose Monitoring
12.4.1.3. Others
12.4.2. Molecular Diagnostics
12.4.3. Immunoassay
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By Country/Sub-region

13. Middle East & Africa Diagnostic Specialty Enzymes Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2017–2031
13.3.1. Proteases
13.3.2. Carbohydrases
13.3.3. Polymerases & Nucleases
13.3.4. Oxidases
13.3.5. Others
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Clinical Chemistry
13.4.1.1. POC Testing
13.4.1.2. Blood Glucose Monitoring
13.4.1.3. Others
13.4.2. Molecular Diagnostics
13.4.3. Immunoassay
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By Country/Sub-region

14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. F. Hoffmann-La Roche Ltd.
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Novozymes A/S
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Codexis, Inc.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. BBI Solutions
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Biocatalysts Ltd.
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Advanced Enzymes Technologies Ltd.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. American Laboratories, Inc.
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Thermo Fisher Scientific Inc.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. Amano Enzyme Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
14.3.10. Amicogen
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview

List of Tables

Table 01: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 06: North America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 07: Europe Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: Europe Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 09: Europe Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 10: Asia Pacific Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 11: Asia Pacific Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 12: Asia Pacific Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 13: Latin America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Latin America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Latin America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 18: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

List of Figures

Figure 01: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

Figure 02: Global Diagnostic Specialty Enzymes Market Revenue (US$ Mn), by Product, 2022

Figure 03: Global Diagnostic Specialty Enzymes Market Value Share, by Product, 2022

Figure 04: Global Diagnostic Specialty Enzymes Market Revenue (US$ Mn), by Application, 2022

Figure 05: Global Diagnostic Specialty Enzymes Market Value Share, by Application, 2022

Figure 06: Global Diagnostic Specialty Enzymes Market Value Share, by Region, 2022

Figure 07: Global Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast, 2023–2031

Figure 08: Global Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 09: Global Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 10: Global Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 11: Global Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

Figure 12: Global Diagnostic Specialty Enzymes Market Value Share Analysis, by Region, 2022–2031

Figure 13: Global Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Region, 2023–2031

Figure 14: North America Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 15: North America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country, 2023–2031

Figure 16: North America Diagnostic Specialty Enzymes Market Value Share Analysis, by Country, 2022–2031

Figure 17: North America Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 18: North America Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 19: North America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 20: North America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

Figure 21: Europe Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 22: Europe Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 23: Europe Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 24: Europe Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 25: Europe Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 26: Europe Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 27: Europe Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

Figure 28: Asia Pacific Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 29: Asia Pacific Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 30: Asia Pacific Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 31: Asia Pacific Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 32: Asia Pacific Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 33: Asia Pacific Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 34: Asia Pacific Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

Figure 35: Latin America Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 36: Latin America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 37: Latin America Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 38: Latin America Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 39: Latin America Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 40: Latin America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 41: Latin America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

Figure 42: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 43: Middle East & Africa Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 44: Middle East & Africa Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 45: Middle East & Africa Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 46: Middle East & Africa Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 47: Middle East & Africa Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 48: Middle East & Africa Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

△ 一番上に戻る